The short answer
Aluminum-containing oral antacids are listed in liothyronine patient guidance as products to keep at least four hours away from the thyroid dose. Direct studies establishing the effect for every aluminum preparation were not found in the sources checked.
What this answer covers
Oral liothyronine and aluminum-containing medicinal antacids. This does not concern metal contact, cookware, trace food exposure or aluminum used in packaging.
- Supplement or preparation
- Aluminum
- Medication ingredient
- liothyronine
Which aluminum exposure matters?
The relevant products are swallowed medicines such as aluminum hydroxide antacids. The NCI drug reference identifies aluminum hydroxide as an acid-neutralizing antacid ingredient. The broad word aluminum should not turn this into a warning about ordinary environmental contact or packaging.
What timing does guidance use?
The liothyronine-specific Alberta monograph recommends keeping aluminum-containing products at least four hours before or after the thyroid medicine. Confirm the active ingredients if the product combines aluminum with magnesium or other antacid ingredients.
Is reduced T3 absorption directly demonstrated?
The inspected monograph states a precaution but does not cite an aluminum-only liothyronine trial. The current Cytomel label discusses reduced absorption with certain binding medicines, without specifically listing aluminum. This supports cautious scheduling while leaving the size and frequency of the effect uncertain.
What if the product changes?
Keep the exact antacid name and frequency available for a medication review. A change from occasional use to several daily doses may make the schedule harder to maintain. Follow prescribed thyroid monitoring rather than adjusting the liothyronine dose to compensate for an assumed interaction.
Evidence and practical considerations
Absorption & effectiveness
Aluminum-containing oral antacids are listed in liothyronine patient guidance as products to keep at least four hours away from the thyroid dose. Direct studies establishing the effect for every aluminum preparation were not found in the sources checked.
- Exact scope
- Oral liothyronine and aluminum-containing medicinal antacids. This does not concern metal contact, cookware, trace food exposure or aluminum used in packaging. with oral liothyronine sodium providing the exact liothyronine active moiety
- Medication form and route
- oral
- Timing or duration
- During co-use; study-specific durations are retained in the source summaries. No universal duration or dose-response inferred.
What remains uncertain
- Secondary exact-drug guidance; no isolated aluminum-antacid/T3 trial or clinical effect size. Aluminum phosphide poisoning research was excluded as the wrong exposure.
Factors that may matter: exact supplement preparation and dose; oral versus nonoral medication route; other formula ingredients; patient thyroid status.
Read the supporting source summaries
Source 1: regulatory product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed oral liothyronine sodium tablets.
T3 dose depends on food, other medicines, clinical response and laboratory results. Table 1 explicitly names resins and bile-acid sequestrants, but does not name the mineral, fiber, soy or botanical pairs evaluated here.
How this applies: Confirms exact liothyronine active moiety, not levothyroxine. Supports monitored individualized treatment; mineral and botanical conclusions require other sources. Exact package scope: Oral liothyronine and aluminum-containing medicinal antacids. This does not concern metal contact, cookware, trace food exposure or aluminum used in packaging.
Absence of a named interaction is not evidence of absence. The four-hour resin instruction cannot automatically be transferred to minerals or fiber.
Source 2: institutional patient medication monograph
myhealth.alberta.ca · Source check Sep 10, 2026
Population: People using oral liothyronine.
Monograph specifically names these products as potentially reducing liothyronine absorption and recommends at least four hours before or after.
How this applies: Exact medication is named. Guidance supports a cautious scheduling recommendation for listed oral products, not a measured clinical effect across every mineral preparation. Exact package scope: Oral liothyronine and aluminum-containing medicinal antacids. This does not concern metal contact, cookware, trace food exposure or aluminum used in packaging.
Secondary patient guidance provides no underlying liothyronine-only trial, salt-specific effect size, threshold dose or validated four-hour comparison.
Source 3: government drug-identity reference
cancer.gov · Source check Sep 10, 2026
Population: Users of oral aluminum hydroxide and magnesium hydroxide suspension.
Identifies these hydroxides as acid-neutralizing antacid ingredients.
How this applies: Supports applying an antacid-class precaution to these acid-neutralizing preparations, not to all aluminum or magnesium exposures. Exact package scope: Oral liothyronine and aluminum-containing medicinal antacids. This does not concern metal contact, cookware, trace food exposure or aluminum used in packaging.
No clinical cefuroxime data or isolated ingredient effect size.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Replaces generic aluminum wording with the oral medicinal-antacid boundary and identifies the lack of directly measured T3 interaction data. | |
| Research summary published |
Article revision: 32c4fee4551372d2
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.